Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of RAPP will rise by +11.53% over the next 2 Weeks and hit $40.32 by Tuesday, April 28, 2026. In that time frame, RAPP's share price is expected to range between $39.02 and $41.76.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Apr 28, 2026 | 39.02 | 40.32 | 41.76 |
| Apr 27, 2026 | 38.26 | 39.58 | 40.92 |
| Apr 24, 2026 | 37.38 | 38.72 | 40.04 |
| Apr 23, 2026 | 37.87 | 39.11 | 40.36 |
| Apr 22, 2026 | 37.45 | 38.74 | 40.00 |
| Apr 21, 2026 | 36.84 | 38.04 | 39.38 |
| Apr 20, 2026 | 36.18 | 37.30 | 38.57 |
| Apr 17, 2026 | 35.29 | 36.44 | 37.66 |
| Apr 16, 2026 | 35.60 | 36.84 | 38.08 |
| Apr 15, 2026 | 35.25 | 36.46 | 37.67 |
RAPP shares rose +1.55% in Wednesday, April 15, 2026's trading session, rising from a previous close of $36.15 to move at $36.71. The stock demonstrated notable intraday movement (see RAPP's key stats for a full breakdown), fluctuating between $35.41 and $36.99, a +4.48% trading range. While recent weeks have seen some volatility, RAPP has managed to secure a +17.32% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 494.7K shares changing hands, 349.69K more than the previous session. This amounted to $18.16M in total market activity.
Will RAPP Continue Its Upward Trend?
According to analyst ratings and projections for RAPP, Rapport Therapeutics, Inc. Common Stock shares are anticipated to increase by +12.08%, potentially reaching $41.76 per share by April 28, 2026. Short-term technical indicators currently suggest a neutral sentiment for RAPP. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the RAPP stock forecast, now is a good time to buy RAPP stock because its current trading price is -8.95% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on RAPP covering social and institutional perspectives.
RAPP Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into RAPP's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 69.23% to 80.66%) indicate the stock is leaning toward a strong bullish momentum phase. The 50-day RSI, at 60.14%, suggests strong medium-term momentum. Additionally, the 100-day RSI, at 56.78%, maintains a neutral outlook for the long term. Insights into RAPP's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Rapport Therapeutics Common Stock Short-Term Forecasts
RAPP Forecast For Next 5 Days
Our algorithm anticipates Rapport Therapeutics Common Stock (RAPP) stock could hit $34.92 by Apr 22, 2026. This represents a -4.88% fall from today's price, following a -3.81% change over the past five days.
RAPP Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Rapport Therapeutics, Inc. Common Stock (RAPP) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $35.87, which would mean a -2.29% decrease from the current price of $36.71. Projections for this period range from a high of $39.70 to a low of $31.67.
RAPP Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Rapport Therapeutics Common Stock's price over the next three months point to a rise. RAPP stock is expected to peak at $43.15 on Jul 16, 2026 after potentially dipping to $32.43 on May 29, 2026. On average, RAPP is likely to trade around $37.02 in the coming 90 days.
Rapport Therapeutics Common Stock Stock Forecast 2025
Based on our predictive models, Rapport Therapeutics Common Stock (RAPP) is expected to trade between $32.43 and $47.38 throughout 2026. This would result in an average price of $38.77, potentially offering investors a +5.61% return from current levels.
Rapport Therapeutics, Inc. Common Stock Monthly Forecast 2026–2027
April 2026
According to our latest forecast models, Rapport Therapeutics, Inc. Common Stock (RAPP) is positioned to show a strong performance in April 2026. The price is predicted to move between $33.42 and $39.18, settling at an average of $36.10. This could translate to a -1.66% loss.
May 2026
Based on current market signals, Rapport Therapeutics, Inc. Common Stock is projected to trend may 2026. We forecast a trading range from $32.43 to $40.10, with a likely average price of $36.55. Investors could expect a potential return of -0.44%.
June 2026
Our predictive algorithms indicate Rapport Therapeutics, Inc. Common Stock stock may see a shift in June 2026. The expected range spans $32.70–$40.10, with an average target of $36.43. This represents a cautious outlook and a possible loss of -0.76%.
July 2026
Analyzing established trends, Rapport Therapeutics, Inc. Common Stock looks set to move in July 2026. Projections place the stock between $35.76 and $43.72, averaging around $40.31. This suggests a +9.81% gain from current levels.
August 2026
Market indicators suggest Rapport Therapeutics, Inc. Common Stock could experience notable changes during August 2026. Prices could fluctuate within $36.30 to $42.80, with a midpoint forecast of $39.49. The stock might deliver a +7.57% gain.
September 2026
Forecasting for September 2026, models estimate that Rapport Therapeutics, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $35.11 and $42.87, averaging $38.52. This signals a positive trajectory with potential returns around +4.93%.
October 2026
According to our latest forecast models, Rapport Therapeutics, Inc. Common Stock (RAPP) is positioned to show a strong performance in October 2026. The price is predicted to move between $34.05 and $47.38, settling at an average of $38.53. This could translate to a +4.96% gain.
November 2026
Based on current market signals, Rapport Therapeutics, Inc. Common Stock is projected to trend november 2026. We forecast a trading range from $35.09 to $46.12, with a likely average price of $38.97. Investors could expect a potential return of +6.16%.
December 2026
Our predictive algorithms indicate Rapport Therapeutics, Inc. Common Stock stock may see a shift in December 2026. The expected range spans $38.39–$45.57, with an average target of $42.41. This represents a positive outlook and a possible gain of +15.53%.
January 2027
Analyzing established trends, Rapport Therapeutics, Inc. Common Stock looks set to move in January 2027. Projections place the stock between $38.23 and $44.81, averaging around $41.37. This suggests a +12.69% gain from current levels.
February 2027
Market indicators suggest Rapport Therapeutics, Inc. Common Stock could experience notable changes during February 2027. Prices could fluctuate within $37.12 to $44.05, with a midpoint forecast of $40.32. The stock might deliver a +9.83% gain.
March 2027
Forecasting for March 2027, models estimate that Rapport Therapeutics, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $36.15 and $44.12, averaging $40.22. This signals a positive trajectory with potential returns around +9.56%.
April 2027
According to our latest forecast models, Rapport Therapeutics, Inc. Common Stock (RAPP) is positioned to show a strong performance in April 2027. The price is predicted to move between $37.51 and $43.52, settling at an average of $40.49. This could translate to a +10.30% gain.
RAPP's history of dividends and stock splits also plays a role in long-term investor confidence.